InvestorsHub Logo

cowtown jay

10/16/20 1:19 PM

#20247 RE: jdc1 #20237

Thank you, jdc1.

If he gets back to you, could you press him further on this thread with Reggie?

"Modifying our Phase III to match the BET endpoints and patient selection criteria was understandable. My understanding was that we had likely completed patient enrollment, and we were going to focus on times to discharge and recovery.

My understanding was NOT that we were NOW going to start enrolling between 200 - 300 patients for our trial, with a focus on preventing cytokine storm."


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942085

drifter

10/16/20 1:22 PM

#20248 RE: jdc1 #20237

I emailed IR about this last night, no reply yet.